Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration - Chakravarthy, U; Adamis, AP; Cunningham, ET, jr.; VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) (Ophthalmology, 2006)